Vedolizumab outperforms infliximab in ulcerative colitis patients who fail first-line treatment, achieving better ...

In patients with ulcerative colitis, vedolizumab outperformed infliximab as a second-line therapy following failure of ...

Better cardiovascular safety and lower risk of all-cause mortality was observed among older adult patients with IBD who received ustekinumab vs vedolizumab.

Entyvio (vedolizumab, Takeda Pharmaceuticals). The researchers enrolled 2,286 ustekinumab-treated patients with ulcerative colitis, who were propensity-score matched 1:1 with vedolizumab-treated ...

Manipal Institute of Virology (MIV) celebrated its Annual Day and Alumni Meet 2025 at Dr TMA Pai Auditorium, MAHE, Manipal, ...

This is especially crucial for those undergoing colectomy or starting biologic treatments like vedolizumab (an immunosuppressive therapy for both Crohn's disease and ulcerative colitis ...

SAN FRANCISCO -- Research presented at the annual Crohn's and Colitis Congress included studies comparing the effectiveness of vedolizumab (Entyvio) versus ustekinumab (Stelara) and of each ...

Shares of Kestra Medical, a wearable cardiac device maker, soared in the company’s public debut this week. Meanwhile, Discord is said to be in ...

AI Mobility provider Webus International, steel industry veteran Luda Technology, Chinese ad services provider LZ Technology and ...

others), ustekinumab (Stelara), or vedolizumab (Entyvio), to reduce inflammation and help close fistulas others, like ciclosporin tacrolimus, azathioprine (Imuran), methotrexate (Jylamvo ...